CNBC Stock Blog
- Mulling Buffett's Stock Advice? Get in With REITs: Fund Managers
- So Now You Can’t Give Microsoft Away?
- Groupon Needs More Disclosure: Analyst
- China’s Steelmakers Set for Turnaround: Analyst
- Bulls Bet Silicon Motion Will Bounce
- Tobacco Stocks a Hot Dividend Play: Analyst
- Forget the Earnings, Disney’s Issue Is the Multiple: Analyst
- Drug Stocks Do Well in ‘Gloom and Doom’ Market: Analyst
ABOUT THE CNBC STOCK BLOG
RSS FEED
CNBC EXPLAINS
Markets Will Drop 7-17% in October: Strategist
CNBC.com Writer
Stocks continued to struggle on Friday. Could this be the beginning of a real market correction? Mike Rubino, president of Rubino Financial, and Paul Schatz, president of Heritage Capital, discussed how investors should position their portfolios for the end of the third quarter.
“I’ve been bullish for a while and over the next year, we’re going higher,” Schatz told CNBC.
“In the interim, the best chance for the first significant correction since the bull leg began in March is coming up early to mid-October."
"It lasts 4 to 6 weeks and we go down 7 to 17 percent. Other than that, we’ve been on an uptrend and it’s going to be a place to buy," Schatz said.
He believes the correction will be healthy for the markets and relatively small, compared to the 50 percent rally since March.
More Investor Intelligence:
In the meantime, Rubino is worried about consumers refusing to open their wallets to spend.
“Consumer spending has no chance of coming back with unemployment soaring and the housing market continuing to deleverage on a nationwide basis," he said. "I don’t see how consumers are comfortable spending when they’re worried about their assets being depleted.”
Schatz Likes:
S&P Consumer Staples
S&P Utilities
S&P Biotechnology
Rubino Likes:
Proshares Trust [TBT
Loading...
()
]
Proshares Short Oil & Gas [DDG
Loading...
()
]
Proshares Short Financials [SEF
Loading...
()
]
______________________________
Disclosure:
No immediate information was available for Rubino or Schatz.
______________________________
CNBC Slideshows:
______________________________
______________________________
Top Biotech Companies:
Amgen [AMGN
Loading...
()
]
Gilead Sciences [GILD
Loading...
()
]
Biogen [BIIB
Loading...
()
]
Genzyme [GENZ
Loading...
()
]
Amylin Pharmaceuticals [AMLN
Loading...
()
]
______________________________











